AVITA Medical, Inc. Sustainability Profile
AVITA Medical, Inc., a pioneering company in regenerative medicine, is headquartered in the United States and operates across key regions globally. Founded in 1993, AVITA has made significant strides in the development of innovative therapies, particularly in the treatment of wounds and skin conditions. The company is renowned for its flagship product, RECELL®, a revolutionary device that enables the rapid preparation of autologous skin cells for the treatment of burns and other skin injuries. This unique approach not only enhances healing but also reduces the need for skin grafts, setting AVITA apart in the competitive medical landscape. With a strong market position and a commitment to advancing patient care, AVITA Medical continues to achieve notable milestones, solidifying its reputation as a leader in the regenerative medicine industry.
DitchCarbon Score
How does AVITA Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AVITA Medical, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AVITA Medical, Inc.'s reported carbon emissions
AVITA Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how AVITA Medical aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the medical technology sector, where companies are increasingly being urged to disclose their environmental impact and set measurable targets for reduction. In summary, AVITA Medical, Inc. has not yet provided emissions data or climate commitments, indicating an opportunity for the company to enhance its sustainability efforts and align with industry best practices.
How Carbon Intensive is AVITA Medical, Inc.'s Industry?
How Carbon Intensive is AVITA Medical, Inc.'s Location?
AVITA Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AVITA Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Hollister Incorporated
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.